Company / Current Assets per Share
NewAmsterdam Pharma Co N.V. Current Assets per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$5.71
FY2025
5-year range
$4.22 / $25.20
FY2022-FY2025
Trend
-37.6%
vs FY2024
Sector context
#119 of 208
Health Care
What the data says
At $5.71, NewAmsterdam Pharma Co N.V.'s current assets per share ranks #119 of 208 in the Health Care sector. Improved from $4.22 to $5.71 over the past 2 years.
Based on SEC 10-K filings.
5.71 in FY2025 with a 3-year CAGR of -39.1%.
Improved from $4.22 to $5.71 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -39.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#119 of 208 in Health CareTop 57% of 208This company $5.71 Sector average $186.87
▼
-96.9% below sector average
Key checks
Key Insights
- In FY2025, current assets per share decreased 37.6% year-over-year.
- Ranks #119 out of 208 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.71 | -37.6% |
| FY2024 | $9.15 | +116.8% |
| FY2023 | $4.22 | -83.3% |
| FY2022 | $25.20 | - |
| FY2021 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026